Navigation Links
Karmanos Researchers Report Enhanced Chemosensitivity of Pancreatic Cancer Cells by Black Seed Component
Date:4/13/2008

Karmanos researchers also discovered at a molecular level, TQ down regulated the normally active NF-B transcription factor and several of its downstream effector genes responsible for metastasis and cell invasion. NF-B is involved in cellular responses to stimuli such as stress, free radicals, ultraviolet irradiation and bacterial or viral antigens. It also plays a key role in regulating the immune response to infection, and is instrumental in the development of many chronic diseases, including cancer. These results suggest that an important molecular target could be down regulated by TQ in reversing chemoresistance, as well as the inhibition of invasion and metastasis of pancreatic cancer.

Further research is currently underway at Karmanos to obtain better clues for TQ's efficacy in future Phase I/II clinical trials. Thus, the research team at Karmanos is actively collaborating with physicians both at the Karmanos Cancer Center and the MD Anderson Cancer Center in Houston, Texas for assessing the clinical utility of TQ.

About the Barbara Ann Karmanos Cancer Institute

Located in mid-town Detroit, MI, the Barbara Ann Karmanos Cancer Institute is one of 39 National Cancer Institute-designated comprehensive cancer centers in the United States. Caring for more than 6,000 new patients annually on a budget of $216 million, conducting more than 700 cancer-specific scientific investigation programs and clinical trials, the Karmanos Cancer Institute is among the nation's best cancer centers. Through the commitment of 1,000 staff, including nearly 300 faculty members, and supported by thousands of volunteer and financial donors, the Institute strives to prevent, detect and eradicate all forms of cancer. John C. Ruckdeschel, M.D., is the Institute's president and chief executive officer. For more information call 1-800-KARMANOS or go to http://www.karmanos.org.

American Association for Cancer
'/>"/>

SOURCE Karmanos Cancer Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. McCarty Cancer Foundation Awards $50,000 Grant for Myeloma Research Program at Karmanos Cancer Institute
2. Nominations for Outstanding Cancer Survivor Award Being Accepted by Karmanos Cancer Institute Through April 27
3. Kroger Pink Tag Campaign Raises $137,500 for Breast Cancer Research and Awareness at Karmanos Cancer Institute
4. Danialle Karmanos Work It Out Launches Dynamic Blog
5. Karmanos Cancer Center Most Preferred Hospital for Cancer Care According to 2007 Survey
6. Susan G. Komen For The Cure, Karmanos Cancer Institute, Local Hospitals Call on Policymakers to Address Injustice and Unfairness in Breast Cancer Incidence and Mortality
7. Susan G. Komen for the Cure, Karmanos Cancer Institute, Community Leaders, Breast Cancer Survivors and Activists to Gather at Forum and Call for Action on Breast Cancer
8. Penn researchers find targeted therapy combination overcomes treatment resistance in liver cancer
9. Researchers find disparities in depression among older Hispanics in US
10. Researchers Identify New Genetic Links to Psoriasis
11. Penn researchers discover modus operandi of heart muscle protein

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...PRNewswire-USNewswire/ -- The U.S. bishops sent an...es November 6, as House members steeped themselves... the health care reform bill. ,, Moments before...l, the bishops called for "a fair process" that wo...place current federal law on abortion funding and ...
(Date:11/6/2009)...ov. 6 Hospira, Inc. (NYS...al and medication delivery company, today announce...ay 21st Annual Health Care Conference on Wednesday...ation is scheduled to begin at 9:30 a.m. Eastern t...ble to all interested parties through a live audio...
(Date:11/6/2009)...oes the need to exert more pressure from the lungs...althDay News) -- Hormonal fluctuations make it har...dy finds. , Many professional singers have diff...known whether this was because of hormones or othe...aby grows. , In this study, researchers followe...
(Date:11/6/2009)...de new lung tissue for certain patients, researche...s) -- Belgian scientists who used embryonic stem c...d provide an alternative to lung transplants for p...e (COPD) and cystic fibrosis. , This is the fir...can be converted into airway epithelial-like cells...
(Date:11/6/2009)...WAVonline - the Value-Added Distributor to Offer V...uct Lines , (PRWEB) Novem...tor of wireless, security, RFID, VoIP and portable...partnered with Vecima Networks Inc. (TSX:VCM), a l...access to cable, wireless and telephony networks. ...
Breaking Medicine News(10 mins):Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 2Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 3Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 4Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 5Health News:WAV Distribution Partners with Vecima Networks Inc. 2Health News:WAV Distribution Partners with Vecima Networks Inc. 3
...r the first time have found a way for the survival...a major breakthrough a Massachusetts scientists w...from an endangered animal (Asian Gaur) and success...to deliver the cloned Asian gaur sometime next mo...
...(known as RU-486 in Europe) has been around for ov...native to surgical abortion in early pregnancy. It... It will be avilable as Mifeprex. Gloria Feld...s the birth-control pill was 40 years ago, It will...
...ave found pore-like holes in the membranes of red ...e malaria parasite. The parasite, Plasmodium falci...f with the nutrients it needs to grow and reproduc...one million people each year, most of them under a...
...tal fibronectin can predict whether a pregnant wom...at high risk for pre-term births are women with pr...station pregnancy, and those who suffer from diabe...classification, and patient presentation; The mark...
...f serum progesterone levels may be helpful in deci...trong clinical signs are at low risk of ectopic pr... of the Annals of Emergency Medicine. They...tients were monitored until intrauterine or ecto...
...ns University research team has discovered a new ...f malignancy, shedding new light on the abnormal...ancer, Burkitt's lymphoma - as well as lymphoma,...hree major types of pediatric non-Hodgkin's lympho...
Other Medicine News:Health News:Feeding channel created by malaria parasite - a new target for ,malaria treatments 2
(Date:11/6/2009)...ETROIT, Nov. 6 Caraco Ph... has launched ketorolac tromethamine ophthalmic so...S Food and Drug Administration (FDA) for Sun Pharm...neric Acular® opthalmic solution on the first... ketorolac is therapeutically equivalent to Acular...
(Date:11/5/2009)...AN DIEGO, Nov. 5 Althea Technolog...anufacturing services for biopharmaceutical produc...n Development to the company,s platform of service...r. James Matsuura, Director of Formulation Develop...rmulation and analytical scientists, along with ne...
(Date:11/5/2009)...ULLERTON, Calif., Nov. 5 Renee Cob...ate professor of dermatology at the University of ...nts are experiencing tremendous results with Therm...ed for skin tightening and contouring, features a ...efficacy and improves patient comfort. ,, "The...
Breaking Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services 2Orange County Dermatologist Garners Outstanding Results With New Thermage CPT(R) 2Implementing QA Automation Tools in an FDA Controlled Software Environment a Free Webinar 14071 1Implementing QA Automation Tools in an FDA Controlled Software Environment a Free Webinar 14071 2Cell Therapeutics Inc s 28CTI 29 Presentation at BioCentury NewsMakers Conference to be Webcast 57296 1GENova Biotherapeutics forming academic partnerships 57293 1GENova Biotherapeutics forming academic partnerships 57293 2
...Mar 6, 2007 - POZEN Inc.,(NASDAQ: POZN), today ann...325 proof-of-concept study conducted during the fo...tion of 325mg of,aspirin surrounded by a 20mg coat...n pump inhibitor., The PA 325, 28 day study, invol...Each subject was treated with either once a day,co...
... 2007 - Accentia,Biopharmaceuticals, Inc. (NASDAQ:...ing of the American Academy of Allergy, Asthma, an...ego, CA. The,posters discussed findings from a sur... in the U.S., U.K., France, and Germany on the,bur...ttitudes of,the fungal etiology of CS, and the dif...
Other Medicine Technology:POZEN Announces Positive Outcome for PA 325 Proof of Concept Study 2POZEN Announces Positive Outcome for PA 325 Proof of Concept Study 3Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 2Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 3Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 4Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 5
NOW® Legionella
OnarLp: Legionella diagnostic for conventional PCR
ResMed VPAP III ST
Probe Tec ET Legionella pneumophila DNA Amplified Assay
Medicine Products: